News
12-19-2017, 05:59 AM
The presence in advanced breast cancer of mutational signatures characteristic of homologous recombination deficiency (HRD) was associated with improved clinical outcomes to treatment with platinum-based chemotherapy.
More... (https://www.news-medical.net/news/20171219/Mutational-patterns-could-identify-breast-cancer-patients-most-likely-to-respond-to-platinum-based-chemotherapy.aspx)
More... (https://www.news-medical.net/news/20171219/Mutational-patterns-could-identify-breast-cancer-patients-most-likely-to-respond-to-platinum-based-chemotherapy.aspx)